Particularly, once SDF-1 is released by CAFs, it binds to a receptor localized in the surface of CCA cells, CXCR4, and modulates the invasive capacity of CCA cells through the ERK1/2 and AKT pathways [133,135]. Here, AKT1 is linked to cholangiocarcinoma.